Company research / MRNA
Moderna, Inc. (MRNA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Moderna, Inc. reported revenue of $1.94B. Revenue fell 39.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.23B.
Key ratios (year ended 2025-12-31)
55.3%
Gross margin (computed)
-158.1%
Operating margin
-145.2%
Net margin
-32.6%
Return on year-end equity
-39.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.